We are live on ! Find out more
FWP

Forward Pharma A/S American Depositary Shares

Delisted

FWP was delisted on the 27th of December, 2022.

12 hedge funds and large institutions have $10.1M invested in Forward Pharma A/S American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

20% more funds holding

Funds holding: 1012 (+2)

12% less capital invested

Capital invested by funds: $11.5M → $10.1M (-$1.39M)

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

FWP Hedge Fund Activity: Q2 2019 in Review

12 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2019, worth a combined $10.1M — down 12% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new FWP positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Newtyn Management, adding an estimated $66.9K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $16K sold.

  • 12 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2019, up from 10 in Q1 2019.
  • Funds reported $10.1M of Forward Pharma A/S American Depositary Shares stock for Q2 2019, down 12% quarter-over-quarter.
  • 4 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2019 and 2 closed out, a net change of +2 holders.
  • The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2019 was Newtyn Management, an estimated $66.9K added.
  • The largest Forward Pharma A/S American Depositary Shares seller in Q2 2019 was Renaissance Technologies, an estimated $16K sold.

Based on aggregated 13F filings for Q2 2019.